Moxifloxacin associated vanishing bile duct syndrome.
Robinson
William
W
Habr
Fadlallah
F
Manlolo
Joseph
J
Bhattacharya
Baishali
B
D000369:Aged, 80 and over; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001372:Aza Compounds / Q000008:administration & dosage / Q000009:adverse effects*; D017963:Azithromycin / Q000009:adverse effects; D001649:Bile Duct Diseases / Q000139:chemically induced*; D002443:Ceftriaxone / Q000009:adverse effects; D024841:Fluoroquinolones; D006801:Humans; D008297:Male; D000077266:Moxifloxacin; D011804:Quinolines / Q000008:administration & dosage / Q000009:adverse effects*; D013577:Syndrome
D000890:Anti-Infective Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D002443:Ceftriaxone; D017963:Azithromycin; D000077266:Moxifloxacin